Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06614127 · ClinicalTrials.gov registry record

Continuous Glucose Monitoring: A Pilot Study

A clinical trial of Anesthesia, sponsored by Loma Linda University.

Active
Registry status
40
Enrollment target
1
Study location

NCT06614127: Active study of Anesthesia, sponsored by Loma Linda University.

NCT06614127 is a study of Anesthesia that is active but no longer recruiting, run by Loma Linda University. The registered enrollment target is 40 participants, below the 109,410-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06614127, a study of Anesthesia, is active but no longer recruiting, sponsored by Loma Linda University.

ACTIVE NOT RECRUITING
Registry status
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate connectivity of the FDA approved DexCom G7® continuous glucose monitor in the operating room. Continuous glucose monitors are applied to the skin and a thin sampling filament is inserted into the skin and measures blood sugar in the interstitial fluid. The DexCom G7® is used regularly outside of the operating room to monitor blood sugar, however the use of the device in the operating room environment has been limited by connectivity issues. This study will assess device connectivity at different monitoring sites.

Primary Outcome

Connectivity will be recorded continuously from start to finish of the procedure. The percentage of time the Dexcom G7® device remains connected during the subject's surgical case will be measured. The effect of electrocautery on CGM connectivity will be assessed by comparing the start and stop times in connectivity to the start and stop times of electrocautery. Connectivity time greater than 80% is considered highly effective. Connectivity time between 20% and 80% is considered effective. Conn

Conditions Studied

Interventions

  • DEVICE Dexcom G7® sensor placed in upper arm and positioned over deltoid
  • DEVICE Dexcom G7® sensor placed in anterior thigh

Study Locations (1)

California

  • Loma Linda University Troesch Medical Center - Loma Linda

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-10-24
Est. Completion 2026-10
Loma Linda University

237 total trials

What the registry record for NCT06614127 still lists

NCT06614127 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 109,410-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Anesthesia appearing as the primary indexed condition, and to 2 interventions - of which Dexcom G7® sensor placed in upper arm and positioned over deltoid is the first listed.

NCT06614127 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06614127 about?

NCT06614127 is a clinical study titled "Continuous Glucose Monitoring: A Pilot Study". The purpose of this study is to evaluate connectivity of the FDA approved DexCom G7® continuous glucose monitor in the operating room. Continuous glucose monitors are applied to the skin and a thin sampling filament is inserted into the skin and measures blood sugar in the interstitial fluid. The De...

What is the current status of trial NCT06614127?

This trial is currently active not recruiting. The enrollment target is 40 participants. The study started on 2024-10-24. Estimated completion is 2026-10.

What conditions does trial NCT06614127 study?

This clinical trial studies the following conditions: Anesthesia.

What interventions are being tested in trial NCT06614127?

The interventions under investigation include: Dexcom G7® sensor placed in upper arm and positioned over deltoid (DEVICE), Dexcom G7® sensor placed in anterior thigh (DEVICE).

Who is sponsoring clinical trial NCT06614127?

This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06614127 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anesthesia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06614127's enrollment target sits among peer trials

40 38th of 57 higher than 16 of 57 other Anesthesia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anesthesia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06614127, the US trial registry maintained by the National Library of Medicine. NCT06614127 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.